Key Highlights

  • The proposed Medicare Advantage audit rule is scheduled to appear in the Federal Register on November 19, 2026, starting a comment period that ends January 19, 2027.
  • Under the plan, payment error rates from sampled patient files would be applied to full plan contracts, starting with 2018 payments, and recoveries are estimated at USD 90.2 billion across 2027 to 2036.
  • Humana (NYSE:HUM) lost 12.98% on November 18, the largest decline in the S&P 500, and UnitedHealth dropped 10.21%, both extending losses from the prior session.
  • A Texas federal court set aside similar provisions in a 2023 rule on procedural grounds, and the government now proposes to bring them back.

The Mechanics of the Proposed Rule

Medicare Advantage plans collect higher payments for enrollees with more serious documented illnesses. Audits that validate risk adjustment data check whether those diagnoses are supported by medical records. Today, any recovery generally applies only to the specific records reviewed. The proposal, issued by the Department of Health and Human Services on November 16 under the label CMS CRUSH rule, would change this by taking the error rate found in a sample of records and applying it to the entire contract. The method would begin with 2018 payment years, and the government puts recoveries at around USD 90.2 billion over 2027 to 2036. The plan revives provisions that a Texas federal court set aside in a 2023 rule for procedural reasons, which implies regulators believe they can address the court's concerns. Publication in the Federal Register on November 19 starts the formal comment period, which closes on January 19, 2027. The agency can only finalize the rule after reviewing those comments, and a final version could draw fresh legal challenges.

Humana's Position Among the Most Exposed

Humana (NYSE:HUM) is one of the most exposed insurers, as Medicare Advantage accounts for a far larger slice of its Business than it does at diversified rivals. Its shares fell 12.98% on November 18 after an earlier decline, making it the weakest S&P 500 performer that day. UnitedHealth shed 10.21% and was the heaviest weight on the Dow Jones Industrial Average, costing the index 561 points. Health care as a whole slipped 2.20%, with CVS Health down 5.20%, Centene 7.03% and Elevance 7.63%. Care providers linked to Medicare Advantage also fell, and agilon health dropped roughly 21%. Market Participants are pricing two distinct risks: retroactive repayments for prior years and a smaller Revenue base if coding habits have to shift. Neither is settled, because any single insurer's bill hinges on its audit findings, its contracts and the litigation that would likely follow.

What Could Follow

The comment window gives insurers, physicians and patient advocates two months to weigh in, and industry groups will likely argue that extrapolating without adjusting for errors in traditional Medicare is unfair. Lawmakers may also speak up, given the program's appeal among seniors. Investors will watch for disclosures that quantify exposure, any guidance changes and the timing of a final rule. Court challenges look probable if the final version resembles the draft.

Where Things Stand

Following a second session of losses for Humana (NYSE:HUM) and UnitedHealth, the CMS Medicare Advantage audit rule is set for print on November 19, with comments accepted until January 19, 2027. Exposure estimates and court challenges will shape what comes next.